|
|
|
1:
Lancet 2000 Jul 15;356(9225):203-8
|
|
Refractory sprue,
cœliac disease,
and enteropathy-associated T-cell lymphoma. French Cœliac Disease
Study Group.
Cellier C, Delabesse E, Helmer C, Patey N, Matuchansky C, Jabri
B, Macintyre E, Cerf-Bensussan N, Brousse N
Department of Gastroenterology, Hopital Laennec, INSERM E9925, Paris,
France. christophe.cellier@egp.ap-hop-paris.fr
BACKGROUND: Adult refractory sprue is a poorly defined disorder.
We did a multicentre national study of patients with refractory
sprue to characterise their clinical and pathological profile and
outcome, and to assess the frequency and prognostic significance
of phenotypic and molecular abnormalities in the intraepithelial
T-cell population. METHODS: Patients with severe symptomatic villous
atrophy mimicking cœliac disease but refractory to a strict gluten-free
diet, and with no initial evidence of overt lymphoma, were diagnosed
at gastrointestinal referral centres between 1974 and 1998. Fixed
and/or frozen duodenojejunal biopsy samples were reanalysed and
immunostained with CD3 and CD8 monoclonal antibodies to find out
the phenotype of intraepithelial lymphocytes (IEL). TCRgamma gene
rearrangements were assessed on frozen biopsy samples by multiplex
fluorescent PCR. FINDINGS: There were 21 patients with refractory
sprue and 20 controls with cœliacs disease. 16 (84%) of 19 assessed
patients had an aberrant intraepithelial lymphoid intestinal population
expressing intracytoplasmic CD3 but not surface CD8. Clonal intestinal
TCRgamma gene rearrangements were found in 13 (76%) of 17 patients
assessed; four (out of 12 assessed) had clonal dissemination to
the blood. The 16 patients with an aberrant phenotype all had uncontrolled
malabsorption; three subsequently developed overt T-cell lymphoma,
and eight died. The three (16%) patients without aberrant clonal
IEL made a complete clinical and histological recovery with steroid
therapy plus a gluten-free diet. INTERPRETATION: An immunophenotypically
aberrant clonal intraepithelial T-cell population (similar to that
of most cases of enteropathy-associated T-cell lymphoma) can be
found in up to 75% of patients with refractory cœliac sprue; its
identification by simple diagnostic techniques represents a marker
of poor outcome (including occurrence of overt T-cell lymphoma).
We suggest that refractory sprue associated with an aberrant clonal
IEL may be the missing link between cœliac disease and T-cell lymphoma
and may be classified as cryptic enteropathy-associated T-cell lymphoma.
Publication Types:
Multicenter study
Comment in:
Lancet. 2000 Jul 15;356(9225):178-9
PMID: 10963198
|
| 2:
Histopathology 2000 Jul;37(1):70-7 |
|
Distinction
between cœliac disease and refractory sprue: a simple immunohistochemical
method.
Patey-Mariaud De Serre N, Cellier C, Jabri B, Delabesse E, Verkarre
V, Roche B, Lavergne A, Briere J, Mauvieux L, Leborgne M, Barbier
JP, Modigliani R, Matuchansky C, MacIntyre E, Cerf-Bensussan N, Brousse
N
Department of Pathology and Universite René Descartes-Paris V (EA
219), INSERM E 9925, Paris, France.
AIMS: We recently showed that refractory sprue is distinct from cœliac
disease, the former being characterized by abnormal intraepithelial
T-lymphocytes expressing a cytoplasmic CD3 chain (CD3c), lacking CD3
and CD8 surface expression, and showing TCRgamma gene rearrangements.
To take advantage of the abnormal phenotype of CD3c + CD8 - intraepithelial
lymphocytes (IEL) in refractory sprue we developed a simple method
to distinguish cœliac disease from refractory sprue. METHODS AND
RESULTS: Comparative immunohistochemical studies using anti-CD3 and
anti-CD8 antibodies were applied on paraffin-embedded and frozen biopsy
specimens in refractory sprue (n = 6), cœliac disease (n = 10), healthy
controls (n = 5) and suspected refractory sprue (n = 6). Comparable
results were obtained on fixed and frozen biopsy specimens. In four
of the six patients with suspected refractory sprue, abnormal CD3c
+ CD8 - IEL and TCRgamma gene rearrangements were found, as in refractory
sprue; the remaining two patients had normal (CD3 + CD8 +) IEL and
no TCRgamma gene rearrangements. Both patients had cœliac disease,
as one failed to comply with a gluten-free diet, while the other was
a slow responder. CONCLUSION: This simplified immunostaining method
using anti-CD3 and anti-CD8 antibodies on paraffin sections can distinguish
active cœliac disease from refractory sprue and should prove useful
in clinical practice.
PMID: 10931221 |
| 3: Gastroenterol
Clin Biol 2000 Apr;24(4):436-46 |
|
[Etiological
diagnosis of villous atrophy].
[Article in French]
Patey-Mariaud De Serre N, Verkarre V, Cellier C, Cerf-Bensussan
N, Schmitz J, Brousse N
Service d'Anatomie et de Cytologie Pathologiques, Centre Hospitalier,
Le Raincy-Montfermeil.
Publication Types:
PMID: 10844289
|
|
2/5
|
|